Giles AI provides a conversational artificial intelligence platform for medical research and clinical trials.
Giles AI provides an artificial intelligence platform designed to streamline workflows across clinical trials, medical research, and regulatory affairs. The conversational system connects organisations to global health data for real-time insights.
Net current assets
Total assets less current liabilities
Shareholders' funds
Current assets
Employees
Cash, assets and headcount from Giles AI's latest Companies House filing — with year-on-year movement, free with a Winfred account.
Rishi Wadhera
Co-founder & CEO
Shahir Raja
Constantin Gorgan
The pre-seed round was backed by Regulatory Scientific and Health Solutions and angel investors to support product development and team growth.